Interactions of 1263W94 with Other Antiviral Agents in Inhibition of Human Cytomegalovirus Replication
Dean W. Selleseth, Christine L. Talarico, Teresa Miller, Michael William Lutz, Karen K. Biron, Robert J. Harvey
Abstract
Dean W. Selleseth, Christine L. Talarico, Teresa Miller, Michael William Lutz, Karen K. Biron, Robert J. Harvey
Abstract
Inhibition of human cytomegalovirus (HCMV) by 1263W94 was additive dosewise in combination with ganciclovir, acyclovir, and foscarnet. None of the commonly used anti-human immunodeficiency virus agents antagonized the inhibition of HCMV by 1263W94. The data were analyzed by a modified isobologram procedure that measures the strength and statistical significance of drug interactions.
OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Inhibition of human cytomegalovirus (HCMV) by 1263W94 was additive dosewise in combination with ganciclovir, acyclovir, and foscarnet. None of the commonly used anti-human immunodeficiency virus agents antagonized the inhibition of HCMV by 1263W94. The data were analyzed by a modified isobologram procedure that measures the strength and statistical significance of drug interactions.
Key concepts: Foscarnet, Ganciclovir, Human cytomegalovirus, Virology, Cytomegalovirus, Viral replication, Replication (statistics), Lentivirus